86
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Safety and efficacy assessment of transarterial chemoembolization using drug-eluting beads in patients with hepatocellular carcinoma and arterioportal shunt: a single-center experience

, , &
Pages 1551-1557 | Published online: 15 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Liang Cai, Honglu Li, Jiang Guo, Wenpeng Zhao, Youjia Duan, Xiaopu Hou, Long Cheng, Hongliu Du, Xihong Shao, Zhenying Diao, Yiwei Hao, Xinmei Zheng, Changqing Li & Wei Li. (2022) Treatment efficacy and safety of drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in hepatocellular carcinoma patients with arterioportal fistula. Cancer Biology & Therapy 23:1, pages 89-95.
Read now
Tian-Cheng Wang, Zi-Shu Zhang & Yu-Dong Xiao. (2020) Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma. Journal of Pain Research 13, pages 649-656.
Read now

Articles from other publishers (13)

Junwei Chen, Lisha Lai, Churen Zhou, Junyang Luo, Haofan Wang, Mingan Li & Mingsheng Huang. (2023) Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus. Cancer Imaging 23:1.
Crossref
Hye Ri Kim, Seung Ho Kim, Yedaun Lee, Jung Hee Son, Eun Joo Park & Ji Hwa Ryu. (2023) Correlation Between Computed Tomography Findings and the Laboratory Test-Derived Severity Score in Patients With Severe Acute Alcoholic Hepatitis. Journal of Computer Assisted Tomography 47:4, pages 548-553.
Crossref
Wenzhe Fan, Bowen Zhu, Xinlin Zheng, Shufan Yue, Mingjian Lu, Huishuang Fan, Liangliang Qiao, Fuliang Li, Guosheng Yuan, Yanqin Wu, Xinhua Zou, Hongyu Wang, Miao Xue & Jiaping Li. (2022) Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization. Journal of Cancer Research and Clinical Oncology 149:5, pages 1873-1882.
Crossref
Juanfang Liu, Wenguang Zhang, Huibin Lu, Hongbin Li, Xueliang Zhou, Jing Li & Xinwei Han. (2021) Drug-eluting bead trans-arterial chemoembolization combined with microwave ablation therapy vs. microwave ablation alone for early stage hepatocellular carcinoma: a preliminary investigation of clinical value. Journal of Cancer Research and Clinical Oncology 148:7, pages 1781-1788.
Crossref
Pin-Ko Chen, Sung-Hua Chiu, Ming-Ting Tsai, Kai-Hsiang Chang, Wei-Chou Chang, Hsuan-Hwai Lin, Cheng-Hsiang Lo, Guo-Shu Huang & Ping-Ying Chang. (2022) Combination therapy of sorafenib and drug-eluting bead transarterial chemoembolization for advanced hepatocellular carcinoma with and without hepatic arteriovenous shunt. Journal of the Chinese Medical Association 85:4, pages 491-499.
Crossref
Hai-lin Lu, Fei-fei Xuan, Yao-chang Luo & Xiao Qin. (2021) Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt. Abdominal Radiology 46:11, pages 5417-5427.
Crossref
Dan Huang, Zhipeng Chen, Yilin Yang, Lelun Jiang, Yang Liu, Yuexiong Yang & Chao Zhang. (2021) Enhanced Embolization Efficacy with the Embolic Microspheres Guided by the Aggregate Gradation Theory Through In Vitro and Simulation Evaluation. Cardiovascular Engineering and Technology 12:4, pages 398-406.
Crossref
Bin Liang, Joyman Makamure, Shenglei Shu, Lijie Zhang, Tao Sun & Chuansheng Zheng. (2021) Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres® Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis. Frontiers in Oncology 11.
Crossref
Pei-Yao Tao, Zi-Shu Zhang, Tian-Cheng Wang, Meng-Qi Yu & Yu-Dong Xiao. (2020) A predictive model of incomplete response after transarterial chemoembolization for early or intermediate stage of hepatocellular carcinoma: consideration of hepatic angiographic and cross-sectional imaging. Abdominal Radiology 46:2, pages 581-589.
Crossref
Yeun-Yoon Kim & Jin-Young Choi. 2021. Radiotherapy of Liver Cancer. Radiotherapy of Liver Cancer 31 49 .
Daizo Fukushima, Shigeki Imai, Noriyuki Nishino, Kohichi Hamada, Yoshinori Horikawa, Yoshiki Shiwa, Shinya Nishida, Ryota Koyanagi, Hitoshi Wada & Hideo Sakuma. (2020) A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy. Clinical Journal of Gastroenterology 13:5, pages 847-854.
Crossref
Juanfang Liu, Jianwei Xu, Wenguang Zhang, Jianjian Chen, Xueliang Zhou, Zhaonan Li & Xinwei Han. (2020) Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma. Academic Radiology 27:5, pages 704-709.
Crossref
Zi-shu Zhang, Hui-zhou Li, Cong Ma & Yu-dong Xiao. (2019) Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety. BMC Cancer 19:1.
Crossref